Javascript must be enabled to continue!
Activation of protein kinase CK2 by LPS is mediated by the MAP kinase pathway
View through CrossRef
Stimulation of macrophages by Gram-negative bacterial lipopolysaccharide (LPS) rapidly leads to the activation of several protein kinases and the subsequent phosphorylation of transcription factors that regulate LPS-inducible genes. Several investigators have shown that the MAP kinases (MAPKs) are rapidly activated following LPS stimulation. We previously reported that LPS stimulation also up-regulates the enzymatic activity of protein kinase CK2, a ubiquitous serine/threonine kinase, although the signaling cascade that leads to CK2 activation in macrophages is unknown. Because MAPKs are known to be rapidly activated by LPS, we performed additional studies in order to determine if CK2 activation was a downstream target of MAPKs. Our studies revealed that CK2 activity was rapidly and transiently up-regulated in LPS-stimulated RAW264.7 murine macrophages. We found that PD98059, an inhibitor of ERK kinase activation by the MAP kinase MEK-1, blocked LPS-induced up-regulation of CK2 activity. In contrast, the p38 kinase inhibitor SB203580 did not block CK2 activation by LPS. This finding suggests that CK2 activation was mediated by the ERK kinase signaling cascade, but not by the p38 kinase cascade. We also found that LPS stimulation resulted in the rapid serine phosphorylation of the catalytic α and α′ subunits of CK2. This contrasts with other studies using growth factor-stimulated fibroblasts in which only phosphorylation of the regulatory β subunit of CK2 was observed. Thus, LPS stimulation leads to rapid activation and cell type-specific phosphorylation of CK2 in macrophages.
SAGE Publications
Title: Activation of protein kinase CK2 by LPS is mediated by the MAP kinase pathway
Description:
Stimulation of macrophages by Gram-negative bacterial lipopolysaccharide (LPS) rapidly leads to the activation of several protein kinases and the subsequent phosphorylation of transcription factors that regulate LPS-inducible genes.
Several investigators have shown that the MAP kinases (MAPKs) are rapidly activated following LPS stimulation.
We previously reported that LPS stimulation also up-regulates the enzymatic activity of protein kinase CK2, a ubiquitous serine/threonine kinase, although the signaling cascade that leads to CK2 activation in macrophages is unknown.
Because MAPKs are known to be rapidly activated by LPS, we performed additional studies in order to determine if CK2 activation was a downstream target of MAPKs.
Our studies revealed that CK2 activity was rapidly and transiently up-regulated in LPS-stimulated RAW264.
7 murine macrophages.
We found that PD98059, an inhibitor of ERK kinase activation by the MAP kinase MEK-1, blocked LPS-induced up-regulation of CK2 activity.
In contrast, the p38 kinase inhibitor SB203580 did not block CK2 activation by LPS.
This finding suggests that CK2 activation was mediated by the ERK kinase signaling cascade, but not by the p38 kinase cascade.
We also found that LPS stimulation resulted in the rapid serine phosphorylation of the catalytic α and α′ subunits of CK2.
This contrasts with other studies using growth factor-stimulated fibroblasts in which only phosphorylation of the regulatory β subunit of CK2 was observed.
Thus, LPS stimulation leads to rapid activation and cell type-specific phosphorylation of CK2 in macrophages.
Related Results
PSIX-19 Leucine supplementation alters immune responses and blood metabolites of lambs exposed to endotoxin
PSIX-19 Leucine supplementation alters immune responses and blood metabolites of lambs exposed to endotoxin
Abstract
This study evaluated effects of supplemental Leu on immune responses and blood metabolites of 29 wether lambs (43.8±10.7 kg) exposed to lipopolysaccharide (...
Copper-mediated regulation of CK2 kinase activity
Copper-mediated regulation of CK2 kinase activity
The evolutionarily conserved serine/threonine kinase CK2 has hundreds of known substrates and plays an essential role in a number of signaling pathways that regulate cell growth an...
Regulation of Human Sickle Erythrocyte Hydration Status by Endothelin-1 Is Mediated by Casein Kinase II.
Regulation of Human Sickle Erythrocyte Hydration Status by Endothelin-1 Is Mediated by Casein Kinase II.
Abstract
Abstract 3020
Poster Board II-996
In Sickle Cell Disease, K+ efflux and osmotically induced water loss leads to erythrocyte de...
Expression and Vascular Effects of Cyclooxygenase-2 in Brain
Expression and Vascular Effects of Cyclooxygenase-2 in Brain
Background and Purpose
—Cyclooxygenase-2 (COX-2) is an inducible isoform of cyclooxygenase. Several types of brain cells in culture can express COX-2 when treated with ...
On Casein Kinase-2 (CK2) deregulation in NSCLC: an enzyme subunit-centered approach
On Casein Kinase-2 (CK2) deregulation in NSCLC: an enzyme subunit-centered approach
Abstract
CK2 is considered a constitutively active protein kinase promoting/supporting several neoplastic properties and inducing a so-called non-oncogene addiction...
Abstract 2527: Regulation of mitotic progression in T-cell acute lymphoblastic leukemia by the Ikaros tumor suppressor
Abstract 2527: Regulation of mitotic progression in T-cell acute lymphoblastic leukemia by the Ikaros tumor suppressor
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that represents a therapeutic challenge. Next-generation sequencing re...
Cardiac protective effects of resveratrol and SIRT1 in old rat with emphysema induced by cigarette smoke-expose and lipopolysaccharide instillation: attenuation of oxidative stress and apoptosis
Cardiac protective effects of resveratrol and SIRT1 in old rat with emphysema induced by cigarette smoke-expose and lipopolysaccharide instillation: attenuation of oxidative stress and apoptosis
Objective
To determine the Cardiac protective effects of resveratrol in old rat with emphysema.
Material and Met...
Conception, synthèse et évaluation d’inhibiteurs de la protéine-kinase CK2
Conception, synthèse et évaluation d’inhibiteurs de la protéine-kinase CK2
CK2 (CSNK2) est une sérine/thréonine-kinase constitutivement active, ubiquitaire, qui contribue à près de 20% du phosphoproteome. Présente sous forme d’un monomère CK2α et égalemen...

